About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy ...

The pharmaceutical industry is undergoing a transformative shift fueled by data analytics. As drug development becomes increasingly complex, analytics is emerging as a key enabler of innovation and ...

Researchers have mapped how microbes underpin our food systems—and how we can stop their decline. Published in Frontiers in ...

This study reveals that artificial intelligence can revolutionize combination therapies by converting ineffective or harmful drug interactions ...

This review systematically analyzes computational frameworks that integrate multi-omics data (genomics, transcriptomics, proteomics) to transform antagonistic drug interactions into synergistic ...

The tumor microenvironment (TME) is a complex and dynamic ecosystem crucial for cancer progression and therapeutic response. Tumors actively shape this ...

Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly ...

National conference titled Connectomics-2025, focusing on the convergence of Omics, Bioinformatics, and Data Science for modern medical research, inaugurated ...

Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced it has achieved ...

Neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, ALS, Huntington’s disease, multiple sclerosis ...

In recent years, the fusion of deep tech with red and gold biotech has ushered in a new era in medicine, one defined by ...